No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50268 |
EHS |
mouse |
spontaneous tumor |
This cell line secretes basement membrane matrix including laminin and type IV collagen. |
|
2 | general cells |
IFO50424 |
AP-16 |
mouse |
brain, astrocyte-progenitor cell |
Astrocyte differentiation is induced by TGF-beta, LIF, CNTF and serum The deprivation of EGF induces death of AP-16 cells by apoptosis. |
|
3 | general cells |
IFO50435 |
KINGS-1 |
human |
brain |
astrocytoma, anaplastic, S-100, vimentin, CD13 and HNK-1-positive, weakly GFAP positive. |
|
4 | general cells |
JCRB0117 |
B104 |
human |
blood |
Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells. |
|
5 | general cells |
JCRB0132.3 |
AH601.P3(JTC27) |
rat |
acites |
AH-601 cell line adupted to a serum free medium with long passage history. |
|
6 | general cells |
JCRB0137 |
RERF-LC-KJ |
human |
lung |
adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes |
|
7 | general cells |
JCRB0169 |
Lu-134-B |
human |
lung |
Small cell lung carcinoma cell line established through heterotransplanted tumor. |
|
8 | general cells |
JCRB0193 |
WB-F344 |
rat |
liver |
Normal liver epitherial cell line from rat, Fischer-344. |
|
9 | general cells |
JCRB0196 |
RP-3 |
mouse |
ascites |
Mouse cell line producing IgM antibody against rat neutrophil. The antibody is harmfull to the rat neutrophil in vivo or in vitro with complement. |
|
10 | general cells |
JCRB0246 |
RC-1 |
rabbit |
cornea |
cornea, (white rabbit) |
|
11 | general cells |
JCRB0248 |
ARLJ301-3 |
rat |
liver |
liver epithelial cell, (F344/DuCrj rat) |
|
12 | general cells |
JCRB0519 |
IMR-90-40 |
human |
lung |
Normal human fibroblast. |
|
13 | general cells |
JCRB0543 |
TIG-110 |
human |
skin |
Normal diploid fibroblast from human skin with limited lifespan. |
|
14 | general cells |
JCRB0731 |
A9(3552)-2 |
human chromosome-introduced |
hybrid |
contains human chromosome 11pter>11q23::Xq26>Xqter (MTA with Tottori Univ. is required.) |
|
15 | general cells |
JCRB1015 |
HSC-1 |
human |
skin |
A cell line of a squamous cell carcinoma of human skin. |
|
16 | general cells |
JCRB1073 |
ASH-3 |
human |
cervical tissue |
Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma. |
|
17 | general cells |
JCRB1081 |
MS-1-L |
human |
pleural effusion |
Human lung small cell carcinoma from pleural effusion. |
|
18 | general cells |
JCRB1201 |
GCH-nu-YS |
human |
nude mouse-transplanted tumor |
Human gestational choriocarcinoma cell line. |
|
19 | general cells |
JCRB1326 |
NCC-RbC-60 |
human |
primary retinoblastoma |
Huaman retinoblastoma cell line. The growth is very slow. |
|
20 | general cells |
JCRB1334 |
RC-K8 |
human |
chylous peritoneal effusion |
A human lymphoma cell line with t(11;14) chromosome abnormality. |
|
21 | general cells |
JCRB1358.06 |
SRBC-F23-20-22 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
22 | general cells |
JCRB1410 |
Kasumi-10 |
human |
blood |
B cell leukemia |
|
23 | general cells |
JCRB1557 |
KKU-213 |
human |
biliary tract |
Human mixed (papillary and non-papillary) cholangiocarcinoma cell line established from biliary tract. |
|
24 | general cells |
JCRB1822 |
NALM-19 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) leukemic cell line. |
|
25 | general cells |
JCRB1864 |
HSC-39 |
human |
ascites |
Human signet ring cell gastric carcinoma cell line establised in vitro from ascites. |
|
26 | general cells |
JCRB1916 |
TCC-NECT-2 |
human |
duodenum |
Duodenal neuroendocrine tumor. Derived from metastatic site: Ascites. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.